Aeron Tynes Hammack, PhD

Board of Directors

Co-founder & Chief Executive Officer

Aeron Tynes Hammack, PhD

Board of Directors

Co-founder & Chief Executive Officer

Dr. Hammack is Chief Executive Officer, Cofounder, and a Director of EpiBiome. He received his bachelor’s degree in Electrical Engineering and Computer Science from The University of California at Berkeley, his PhD in Physics from UCSD, and was a postdoctoral fellow at LBNL. Dr. Hammack has more than 20 peer-reviewed publications in topics ranging from superfluidity, polymers, and surface chemistry to plasmonics and photonics. Before founding EpiBiome, he was a Research Staff Member at HGST where he developed nanoscale optical characterization techniques. In his current role at EpiBiome, he brings expertise in programming and data analysis, and oversees the bioinformatics program. Dr. Hammack is also an expert in microscopy and spectroscopy.

Nick Conley, PhD

Board of Directors

Co-founder & Chief Science Officer

Nick Conley, PhD

Board of Directors

Co-founder & Chief Science Officer

Dr. Conley is Chief Science Officer, Co-founder, and a Director of EpiBiome. He completed a PhD in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University, where he trained as a synthetic chemist and molecular biologist. Dr. Conley possesses a direct Nobel Laureate pedigree, having worked with Prof. W. E. Moerner at Stanford University, winner of the 2014 Nobel Prize in Chemistry. Dr. Conley was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has published 18 peer-reviewed journal articles on topics including palladium catalysis, super-resolution fluorescence imaging, single-molecule DNA detection, and cancer biology, and he holds four U.S. patents. Prior to founding EpiBiome, Dr. Conley was a Research Staff Member at HGST, a Western Digital Company.

Chris Lowe

Chris Lowe

Board of Directors

Chris Lowe

Board of Directors

Chris Lowe is currently a partner at FLG, a leading CFO consulting and board advisory firm. Most recently serving as interim CEO and CFO at Hansen Medical, Chris has over 15 years of senior management experience as CEO, CBO and CFO of various private and public life sciences, medical technology, and technology companies. Additionally, he has served as a member of the Board of Directors of both public and private companies, and has chaired their respective Audit Committees and Compensation Committees. Chris helps companies succeed by assisting them with corporate and financial strategy, including early stage financing, successive fundraising and IPOs, public company advising and Wall Street communications, licensing transactions, M&A, restructurings and coaching at every level of the C-Suite. In particular, he excels at helping companies navigate the challenges of accessing capital, M&A, licensing, restructurings and exits. During his career as a C-level executive, Chris has successfully raised over $500M in private and public financings, completed over $1.0B in M&A transactions, negotiated over $300M in debt instruments for companies, and has overseen three SOX-404 implementations. Chris earned his B.S. from California Polytechnic State University, San Luis Obispo, and a MBA from St Mary’s University.